1887
Preview this article:
Zoom in
Zoomout

Use of ciprofloxacin for treating leptospirosis – need for clinical trials, Page 1 of 1

| /docserver/preview/fulltext/jmm/54/9/jmm549.907-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45978-0
2005-09-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/9/JM540918.html?itemId=/content/journal/jmm/10.1099/jmm.0.45978-0&mimeType=html&fmt=ahah

References

  1. Bharadwaj, R., Bal, A. M., Joshi, S. A., Kagal, A., Pol, S. S., Garad, G., Arjunwadkar, V. & Katti, R. ( 2002;). An urban outbreak of leptospirosis in Mumbai, India. Jpn J Infect Dis 55, 194–196.
    [Google Scholar]
  2. Emmanouilides, C. E., Kohn, O. F. & Garibaldi, R. ( 1994;). Leptospirosis complicated by a Jarisch-Herxheimer reaction and adult respiratory distress syndrome: case report. Clin Infect Dis 18, 1004–1006.[CrossRef]
    [Google Scholar]
  3. Guidugli, F., Castro, A. A. & Atallah, A. N. ( 2000;). Antibiotics for treating leptospirosis. Cochrane Database Syst Rev 2, CD001306. CD001306.
    [Google Scholar]
  4. Gussenhoven, G. C., van der Hoorn, M. A., Goris, M. G., Terpstra, W. J., Hartskeerl, R. A., Mol, B. W., van Ingen, C. W. & Smits, H. L. ( 1997;). LEPTO dipstick, a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human sera. J Clin Microbiol 35, 92–97.
    [Google Scholar]
  5. Hooper, D. C. ( 2000;). Quinolones. In Principles and Practice of Infectious Diseases, pp. 404–423. Edited by G. L. Mandell, J. E. Bennett & R. Dolin. Philadelphia: Churchill Livingstone.
  6. Mancel, E., Merien, F., Pesenti, L., Salino, D., Angibaud, G. & Perolat, P. ( 1999;). Clinical aspects of ocular leptospirosis in New Caledonia (South Pacific). Aust N Z J Ophthalmol 27, 380–386.[CrossRef]
    [Google Scholar]
  7. Shalit, I., Barnea, A. & Shahar, A. ( 1989;). Efficacy of ciprofloxacin against Leptospira interrogans serogroup icterohaemorrhagiae. Antimicrob Agents Chemother 33, 788–789.[CrossRef]
    [Google Scholar]
  8. Sugunan, A. P., Natarajaseenivasan, K., Vijayachari, P. & Sehgal, S. C. ( 2004;). Percutaneous exposure resulting in laboratory-acquired leptospirosis – a case report. J Med Microbiol 53, 1259–1262.[CrossRef]
    [Google Scholar]
  9. Takashima, I., Ngoma, M. & Hashimoto, N. ( 1993;). Antimicrobial effects of a new carboxyquinolone drug, Q-35, on five serogroups of Leptospira interrogans. Antimicrob Agents Chemother 37, 901–902.[CrossRef]
    [Google Scholar]
  10. Tappero, J. W., Ashford, D. A. & Perkins, B. A. ( 2000;). Leptospira species (Leptospirosis). In Principles and Practice of Infectious Diseases, pp. 2495–2501. Edited by G. L. Mandell, J. E. Bennett & R. Dolin. Philadelphia: Churchill Livingstone.
  11. Truccolo, J., Charavay, F., Merien, F. & Perolat, P. ( 2002;). Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother 46, 848–853.[CrossRef]
    [Google Scholar]
  12. Watt, G., Padre, L. P., Tuazon, M. L., Calubaquib, C., Santiago, E., Ranoa, C. P. & Laughlin, L. W. ( 1988;). Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet i, 433–435.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45978-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error